Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ISEC HealthcareSGX:40T 64 Return-on-Tangible-Equity is 23.27% as of Mar. 2026, which is 25% below its 10-year median of 30.91. GuruFocus rates SGX:40T with a GF Score™ of 64/100 and a GF Value™ of S$0.45 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 575 Healthcare Providers & Services companies, ISEC Healthcare ranks better than 76.87% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. ISEC Healthcare's annualized net income for the quarter that ended in Mar. 2026 was S$11.35 Mil. ISEC Healthcare's average shareholder tangible equity for the quarter that ended in Mar. 2026 was S$48.78 Mil. Therefore, ISEC Healthcare's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 23.27%.
The historical rank and industry rank for ISEC Healthcare's Return-on-Tangible-Equity or its related term are showing as below:
SGX:40T'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 17.39 Med: 30.91 Max: 50.23
Current: 29.74
During the past 13 years, ISEC Healthcare's highest Return-on-Tangible-Equity was 50.23%. The lowest was 17.39%. And the median was 30.91%.
SGX:40T's Return-on-Tangible-Equity is ranked better than 76.87% of 575
companies
in the Healthcare Providers & Services industry
Industry Median: 10.56
vs SGX:40T: 29.74
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
ISEC Healthcare Return-on-Tangible-Equity Related Terms
ISEC Healthcare Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for ISEC Healthcare's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:40T vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, ISEC Healthcare's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ISEC Healthcare Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, ISEC Healthcare's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where ISEC Healthcare's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 23.27% mean?
ISEC Healthcare (SGX:40T) has a Return-on-Tangible-Equity of 23.27% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on ISEC Healthcare and its competitors. This is 25% below median its historical median of 30.91. Over the past decade, ISEC Healthcare's Return-on-Tangible-Equity has ranged from 17.39 to 50.23. According to the industry distribution chart, ISEC Healthcare ranks #133 out of 575 companies in the Healthcare Providers & Services industry, placing it in the top 23.1%.
Is ISEC Healthcare's Return-on-Tangible-Equity too high?
ISEC Healthcare's current Return-on-Tangible-Equity of 23.27% is 25% below median its 10-year median of 30.91. Over the past 10 years, this metric has ranged from a low of 17.39 to a high of 50.23. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.56. ISEC Healthcare's value of 23.27% is 120.4% above this industry median. Based on the distribution chart, ISEC Healthcare ranks #133 out of 575 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, ISEC Healthcare has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ISEC Healthcare's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, ISEC Healthcare ranks #133 out of 575 companies for Return-on-Tangible-Equity. This places ISEC Healthcare in the top 23% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 10.56. ISEC Healthcare's value of 23.27% is 120.4% above this benchmark. Historically, ISEC Healthcare's own Return-on-Tangible-Equity has ranged from 17.39 to 50.23 over the past decade. While the company's 10-year median is 30.91 vs. the industry median of 10.56, ISEC Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.56, based on 575 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ISEC Healthcare's current Return-on-Tangible-Equity of 23.27% is 120.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on ISEC Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ISEC Healthcare's current Return-on-Tangible-Equity is 23.27%, which is 25% below median its own 10-year median of 30.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ISEC Healthcare stock overvalued right now?
Based on GuruFocus' analysis, ISEC Healthcare (SGX:40T) is currently considered Modestly Undervalued. The stock's GF Value™ is S$0.45, compared to a current price of S$0.32 — trading 28.9% below its estimated fair value. The current Return-on-Tangible-Equity is 23.27%, which is 25% below median its 10-year median of 30.91 and 120.4% above the Healthcare Providers & Services industry median of 10.56. ISEC Healthcare's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For ISEC Healthcare (SGX:40T), the current Return-on-Tangible-Equity is 23.27% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ISEC Healthcare (SGX:40T) Overvalued in 2026?
Based on GuruFocus' analysis, ISEC Healthcare stock appears to be undervalued.
The current stock price of S$0.32 is trading 28.9% below its estimated GF Value™ of S$0.45.
GuruFocus considers ISEC Healthcare to be Modestly Undervalued.
Key valuation signals for SGX:40T:
Return-on-Tangible-Equity: 23.27% (25% below median its 10-year median of 30.91)
GF Value™: S$0.45 vs. price of S$0.32 (28.9% below fair value)
Industry Position: 120.4% above the Healthcare Providers & Services median (#133 of 575)
No single metric tells the full story. See the SGX:40T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ISEC Healthcare Ltd principal activity of the Company is that of an investment holding company. It is regional provider of comprehensive medical eye care services with ambulatory surgical centres. The company has two reportable segment which are Specialised health services: provision of medical care, consultancy, treatment and surgery in the field of ophthalmology; and General health services: provision of general medical and procedural treatment services. The majority of revenue comes from Specialised health services segment. The company has presence in Singapore, Malaysia, and Myanmar. The company generates majority of revenue from Malaysia.
64GF Score
Get the complete analysis for SGX:40T
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:40T has been successfully added to your 
